Effects of Prenatal Spironolactone on Mouse Brain Development
Author Information
Author(s): Jones Stephanie M., Sleiman Sarah Jo, McCann Katharine E., Jarmusch Alan K., Alexander Georgia M., Dudek Serena M.
Primary Institution: National Institute of Environmental Health Sciences
Hypothesis
Disturbing mineralocorticoid receptor function during early development may impair the establishment of CA2 connectivity and its role in behavior.
Conclusion
Prenatal exposure to spironolactone disrupts hippocampal CA2 connectivity and alters behavior in mice, leading to increased reactivity to novel objects but no change in social novelty preference.
Supporting Evidence
- Spironolactone treatment caused a significant reduction of CA2 axon fluorescence intensity in the CA1 stratum oriens.
- vGluT2 staining was significantly decreased in both CA2 and dentate gyrus in spironolactone-treated animals.
- Spironolactone-treated animals exhibited increased reactivity to novel objects.
- Prenatal MR inhibition did not cause lasting disruption of CA2 markers detected in adulthood.
Takeaway
Mice whose mothers took a certain medicine while pregnant acted differently when they saw new things, but they didn't change how they reacted to new friends.
Methodology
Mice were treated with spironolactone during pregnancy, and their behavior and brain connectivity were assessed in adulthood.
Potential Biases
Potential confounding factors from the treatment and environmental conditions were not fully controlled.
Limitations
The study primarily focuses on the effects of spironolactone and does not explore other potential influences on behavior.
Participant Demographics
C57BL/6J mice, both male and female, were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website